The effect of mechanical grinding on the formation, crystalline changes and dissolution behaviour of the inclusion complex of telmisartan and β-cyclodextrins

被引:43
作者
Amarante Borba, Paola Aline [1 ]
Pinotti, Mariha [1 ]
Santana Andrade, George Ricardo [2 ]
da Costa, Nivan Bezerra, Jr. [2 ,3 ]
Olchanheski Junior, Luiz Renato [4 ]
Fernandes, Daniel [4 ]
Maduro de Campos, Carlos Eduardo [5 ]
Stulzer, Hellen Karine [1 ]
机构
[1] Univ Fed Santa Catarina, Programa Posgrad Farm, BR-88040970 Florianopolis, SC, Brazil
[2] Univ Fed Sergipe, Programa Posgrad Engn & Ciencias Mat, BR-49000100 Sao Cristovao, SE, Brazil
[3] Univ Fed Sergipe, Dept Quim, BR-49000100 Sao Cristovao, SE, Brazil
[4] Univ Estadual Ponta Grossa, Dept Ciencias Farmaceut, BR-84030900 Ponta Grossa, PR, Brazil
[5] Univ Fed Santa Catarina, Dept Fis, BR-88040970 Florianopolis, SC, Brazil
关键词
Telmisartan; beta-Cyclodextrin; Mechanical grinding process; Molecular inclusion complex; Molecular modeling; In vivo studies; IN-VITRO DISSOLUTION; SOLID DISPERSIONS; PHYSICAL STABILITY; DRUG SOLUBILITY; X-RAY; STABILIZATION; BIOAVAILABILITY; EFFICIENCY; DISCOVERY; RELEASE;
D O I
10.1016/j.carbpol.2015.06.098
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Telmisartan (TEL) was entrapped into beta-cyclodextrin aiming the improvement of its biopharmaceutical properties of low solubility. A solid state grinding process was used to prepare the molecular inclusion complex (MIC) for up to 30 min. The inclusion ratio of drug and P-cyclodextrin was established as 1:2 and 1:3 (mol/mol) by phase solubility study and Job Plot. DSC, XRPD and FTIR confirmed the molecular interactions between TEL and beta-cyclodextrin. Computer molecular modeling supports the presence of hydrogen bonds between guest and host and demonstrated the most probable complexes configuration. MIC_1 :2_30 and MIC_1 :3_30 enhanced the dissolution rate of the drug achieving a delivery rate comparable with the reference medicine available in the market (81% and 87% in 5 min, for MIC_1 :3_30 and Micardis (R)), respectively). These formulations showed rapid and effective antihypertensive effect against angiotensin II in rats up to 180 min, with statistically significant results against placebo and control in the first 30 min after administration. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:373 / 383
页数:11
相关论文
共 55 条
[1]   Prediction of deferiprone solubility in aqueous mixtures of ethylene glycol, propylene glycol and polyethylene glycol 400 at various temperatures [J].
Abbasi, Masoumeh ;
Martinez, Fleming ;
Jouyban, Abolghasem .
JOURNAL OF MOLECULAR LIQUIDS, 2014, 197 :171-175
[2]   DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding [J].
Aigner, Z. ;
Berkesi, O. ;
Farkas, G. ;
Szabo-Revesz, P. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 57 :62-67
[3]   An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles [J].
Anderson, NH ;
Bauer, M ;
Boussac, N ;
Khan-Malek, R ;
Munden, P ;
Sardaro, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (4-5) :811-822
[4]   Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide) [J].
Barzegar-Jalali, Mohammad ;
Valizadeh, Hadi ;
Shadbad, Mohammad-Reza Siahi ;
Adibkia, Khosro ;
Mohammadi, Ghobad ;
Farahani, Amin ;
Arash, Zeynab ;
Nokhodchi, Ali .
POWDER TECHNOLOGY, 2010, 197 (03) :150-158
[5]  
Borba PAA, 2014, LAT AM J PHARM, V33, P557
[6]  
British Pharmacopoeia, 2012, TELM MON BRIT PHARM, V1
[7]   The utility of cyclodextrins for enhancing oral bioavailability [J].
Carrier, Rebecca L. ;
Miller, Lee A. ;
Ahmed, Mran .
JOURNAL OF CONTROLLED RELEASE, 2007, 123 (02) :78-99
[8]   Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and amorphous phase physical stability [J].
Crowley, KJ ;
Zografi, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (02) :492-507
[9]   Cyclodextrins and their uses: a review [J].
Del Valle, EMM .
PROCESS BIOCHEMISTRY, 2004, 39 (09) :1033-1046
[10]  
Dinnebier RE, 2000, J PHARM SCI, V89, P1465, DOI 10.1002/1520-6017(200011)89:11<1465::AID-JPS9>3.0.CO